Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China

Affiliations

Lu Li: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China
Shilei Yang: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China
Fengqi Fang: Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China
Li Tian: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China
Ying He: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China
Jia Li: Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China
Yanwei Chen: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China
Deshi Dong: Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, China

Abstract

No abstracts available.